Challenges in Ensuring Equity In the Study and Treatment of ME/CFS and Long Covid
Co-presented by Peter Rowe, MD (Professor of Pediatrics, Director, Johns Hopkins Children’s Center Chronic Fatigue Clinic) and Camille Broussard, MD, MPH (Assistant Professor in the Division of Adolescent and Young […]
Long Covid in the Media
Solve M.E. is continuing our event series with the Global Interdependence Center with a panel on November 29 10AM PT. The sixth installment of the GIC Solve Long Covid Initiative […]
Understanding the Biomarkers of PASC (otherwise known as Long Covid)
The RECOVER Research Review (R3) Seminar Series will host a panel discussion titled, “Understanding the Biomarkers of PASC” on Tuesday, November 8th 12:00-1:30 PM EDT featuring: Michael Peluso, MD, University […]
RECOVER Study of Paxlovid to Treat Long Covid Begins January 2023, Has Implications for ME/CFS
The National Institutes of Health (NIH) announced that the use of Paxlovid to treat Long Covid will be the first treatment to be studied by its $1 billion RECOVER Initiative. […]
Fiona Lowenstein, Dona Kim Murphey and The Long Covid Survival Guide
For people living with Long Covid, navigating the uncharted territory of this new chronic illness can be challenging. With over two hundred unique symptoms, and with doctors continuing to work […]
World ME Alliance calls on WHO Director General to recognize ME/CFS alongside Long Covid
On Wednesday 12th October Dr. Tedros Ghebreyesus, Director General of the World Health Organization, wrote an op-ed in the Guardian. In it, he lays clear the devastation that Long Covid […]
New Ramsay Grant Researchers Push the Envelope with Innovative ME/CFS & Long Covid studies
We’re excited to share the newest class of Ramsay Researchers! Since its launch, our Ramsay Research Grant Program has been successful in attracting new scientists to the fields of ME/CFS […]
Breaking News: FDA clears Ampligen to start a clinical trial in Long Covid
A decade after the U.S. Food and Drug Administration (FDA) did not approve Ampligen (rintatolimod) for the treatment of ME/CFS, this antiviral and immuno-modulator drug is getting a rare second chance. […]
New Diagnostic Codes for ME/CFS in the U.S. ICD-10-CM
Starting this month, doctors will be able to add a unique code for ME/CFS into your medical record — G93.32. Going forward, Americans diagnosed with ME/CFS, including any new cases following […]
$15 Million Long Covid Research Venture Has Roots in Solve M.E. Ramsay Awards
Last week, the PolyBio Research Foundation announced the launch of their Long Covid Research Initiative (LCRI), to search for drivers of this condition and ultimately find treatments to help the […]
Aila Health Presents Free Virtual Long Covid Summit
Our friends at Aila Health are hosting a free Long Covid Summit on Wednesday, September 21 8 AM – 3 PM PT to bring together specialists, longhaulers, caregivers, advocacy organizations, […]
COVID-19 as a Trigger for ME/CFS: Severity Biomarkers and Underlying Mechanisms
Since the beginning of the pandemic, SARS-CoV-2 has been suspected of causing chronic fatigue syndrome (ME/CFS). A well-controlled cohort study conducted by a group of researchers from Charité – Universitätsmedizin […]
